This grant from the National Institute of Diabetes and Digestive and Kidney Diseases aims to fund Small Business Innovation Research projects focused on the development of innovative technologies and bioengineering solutions to enhance cell replacement therapies for Type 1 Diabetes. Specifically, the grant supports research on novel biomaterials and devices to improve interventions for Type 1 Diabetes treatment. Applications are encouraged to contribute to the advancement of cell replacement therapies in the field of T1D. Deadline for submission is March 21, 2018.
Opportunity ID: 299619
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-17-030 |
| Funding Opportunity Title: | Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 21, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Mar 21, 2018 |
| Current Closing Date for Applications: | Mar 21, 2018 |
| Archive Date: | Apr 26, 2018 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding announcement for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel biomaterials and devices for type 1 diabetes (T1D) treatment. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-030.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00237222 | Feb 21, 2018 | Mar 21, 2018 | View |
Package 1
Mandatory forms
299619 RR_SF424_2_0-2.0.pdf
299619 PHS398_CoverPageSupplement_4_0-4.0.pdf
299619 RR_OtherProjectInfo_1_4-1.4.pdf
299619 PerformanceSite_2_0-2.0.pdf
299619 RR_KeyPersonExpanded_2_0-2.0.pdf
299619 RR_Budget_1_4-1.4.pdf
299619 PHS398_ResearchPlan_4_0-4.0.pdf
299619 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
299619 RR_SubawardBudget30_1_4-1.4.pdf
299619 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
